Nuclear Pharmacy

UPPI LLC (United Pharmacy Partners) Proudly Announces That Thirty-One (31) Nuclear Pharmacy Members & Affiliates Received a Recognition Award from the U.S. Department of Energy

SUWANEE, Ga.–(BUSINESS WIRE)–UPPI LLC (United Pharmacy Partners) is proud to announce that thirty-one (31) nuclear pharmacy members and affiliates have received a Recognition Award from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) from Assistant Deputy Administrator Peter H. Hanlon in recognition of providing radiopharmaceuticals of molybdenum 99/technetium 99m derived from sources with […]

Read More...

Nuclear Medicine Radiation Safety in Adult Medical Imaging

The 2009 National Council on Radiation Protection and Measurements, Report No. 160 — Ionizing Radiation Exposure of the Population of the United States — showed that medical exposure to patients is one of the largest sources of radiation exposure to Americans, nearly equaling the exposure from background sources. Nuclear medicine is the second largest source […]

Read More...

FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors

The U.S. Food and Drug Administration today approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging. This radioactive probe will help locate tumors in adult and pediatric patients with the rare condition, somatostatin receptor positive neuroendocrine tumors (NETs). NETs are […]

Read More...

FDA Approves New PET Imaging Agent for Recurrent Prostate Cancer

Today Blue Earth Diagnostics announced that the FDA has approved AxuminTM (F-18-labeled fluciclovine injection) for detecting biochemical recurrence of prostate cancer. It is the first FDA-approved F-18-labeled PET imaging agent for use in patients with suspected recurrent prostate cancer. Prostate cancer is the second leading cause of cancer death in men. While most primary prostate […]

Read More...

Task Force Develops New Radiation Guidelines For Brachytherapy

Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of Medical Physics in the department of Radiation Oncology at Thomas Jefferson University. The guideline was issued by […]

Read More...